<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343038">
  <stage>Registered</stage>
  <submitdate>8/06/2011</submitdate>
  <approvaldate>10/06/2011</approvaldate>
  <actrnumber>ACTRN12611000600943</actrnumber>
  <trial_identification>
    <studytitle>Percutaneous Nephrostomy versus Emergency Percutaneous Nephrolithotomy of Sepsis Associated with Uretero-Pelvic Junctional Stone Impaction: A Randomized Controlled Trial</studytitle>
    <scientifictitle>Percutaneous nephrostomy versus emergency percutaneous nephrolithotomy of sepsis associated with uretero-pelvic stone impaction</scientifictitle>
    <utrn>U1111-1121-9931</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>sepsis associated with uretero-pelvic junctional stone impaction</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Kidney disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>emergency percutaneous nephrolithotomy for decompression of the collecting system in cases of sepsis associated with uretero-pelvic junctional stone impaction.(Under endotracheal anesthesia and sonographic guided,percutaneous nephrolithotomy was done to remove the impacted stone with double-J catheter indwelling for internal drainage upon admission,the whole course will take 30 minutes)</interventions>
    <comparator>percutaneous nephrostomy for decompression of the collecting system in cases of sepsis associated with uretero-pelvic junctional stone impaction(Under local anesthesia and sonographic guided,percutaneous nephrostomy was done to for decompression of hydronephrosis upon admission.it will take 20 minutes. After sepsis resolved,elective percutaneous nephrolithotomy was done to remove the impacted stone with double-J catheter indwelling for internal drainage)</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>time to normalization of WBC of 10,000/mm. or less(check complete blood count once a day during the admission)</outcome>
      <timepoint>time to normalization of WBC of 10,000/mm. or less(check complete blood count once a day during the admission)</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>time to normalization of body temperature of 37.4 degrees celsius or less by tympanic thermometer.</outcome>
      <timepoint>body temperature of 37.4 degrees celsius by tympanic thermometer</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>analgesic consumption(oral Ketolorac 10 mg three time per day for 1 week if needed,total doses recorded by medical records)</outcome>
      <timepoint>oral Ketolorac 10 mg three time per day 1 week post surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>length of stay(days,data linkage to patient medical records)</outcome>
      <timepoint>days of admission(data linkage to patient medical records)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult patients presenting to the emergency room or admitted to the hospital with obstructing uretero-pelvic junctional stones and clinical signs of sepsis were asked to participate in this randomized study. The inclusion criteria included a white blood count (WBC) of 10,000 mm. or greater and or temperature 38 degrees celsius or greater.</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>uncorrected coagulopathy, urinary diversion, pregnancy, solitary kidney, and unwillingness or impossibility to commit to the study follow-up protocol.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>numbered containers</concealment>
    <sequence>random numbers table</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/01/2007</anticipatedstartdate>
    <actualstartdate>1/01/2007</actualstartdate>
    <anticipatedenddate>31/07/2012</anticipatedenddate>
    <actualenddate>31/07/2012</actualenddate>
    <samplesize>45</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Taiwan, Province Of China</country>
      <state>Taiwan</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Chung Jing Wang</primarysponsorname>
    <primarysponsoraddress>60058 No 565 Rd Ta-Ya Chia-yi city Taiwan ROC St Martin De Porres Hospital</primarysponsoraddress>
    <primarysponsorcountry>Taiwan, Province Of China</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Chung Jing Wang</fundingname>
      <fundingaddress>60058 No 565 Rd Ta-Ya Chia-yi city Taiwan ROC St Martin De Porres Hospital</fundingaddress>
      <fundingcountry>Taiwan, Province Of China</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A randomized trial with evaluation of  the efficacy, related complications and convalescence of emergency percutaneous nephrolithotomy instead of percutaneous nephrostomy for decompression of the collecting system in cases of sepsis associated with uretero-pelvic junctional stone impaction.</summary>
    <trialwebsite />
    <publication>not yet</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>IRB STM</ethicname>
      <ethicaddress>60058  No 565 Rd Ta-Ya Chia-Yi city Taiwan ROC
St Martin De Porres Hospital</ethicaddress>
      <ethicapprovaldate>15/11/2006</ethicapprovaldate>
      <hrec>STM IRB-2006-17</hrec>
      <ethicsubmitdate>24/10/2006</ethicsubmitdate>
      <ethiccountry>Taiwan, Province Of China</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Chung Jing Wang</name>
      <address>60058 No 565 Rd Ta-Ya Chia-yi city Taiwan ROC St Martin De Porres Hospital</address>
      <phone>886-5-2756000-1013</phone>
      <fax>886-5-2788535</fax>
      <email>jing@stm.org.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Chung Jing Wang</name>
      <address>60058 No 565 Rd Ta-Ya Chia-yi city Taiwan ROC St Martin De Porres Hospital</address>
      <phone>886-5-2756000-1013</phone>
      <fax>886-5-2788535</fax>
      <email>jing@stm.org.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Chung Jing Wang</name>
      <address>60058 No 565 Rd Ta-Ya Chia-yi city Taiwan ROC St Martin De Porres Hospital</address>
      <phone>886-5-2756000-1013</phone>
      <fax>886-5-2788535</fax>
      <email>jing@stm.org.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Chung Jing Wang</name>
      <address>60058 No 565 Rd Ta-Ya Chia-yi city Taiwan ROC St Martin De Porres Hospital</address>
      <phone>886-5-2756000-1013</phone>
      <fax>886-5-2788535</fax>
      <email>jing@stm.org.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>